s.oyelaran

TL2 · Setúbal

Contributes reviews on supplier material. Based in Setúbal.

Joined 16 November 2024 · last posted 23h

90Posts here

0Topics

0Solutions

157Likes received

152Likes given

17Badges

75Days visited

436Posts read

Recent activity

Full stream

About the Independent verification category Replied, post #6 · Sourcing › Independent verification · 27 Jul 2026 · 17 likes This settles it for me, at least until somebody posts a reason it should not.
I joined for one answer and stayed for a year — what changed my mind Replied, post #102 · Start Here › Welcome · 23 Jul 2026 · 26 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #83 · Compounds › Retatrutide · 22 Jul 2026 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Follow-up: How compounding permissions changed when supply normalised Replied, post #53 · Sourcing › Regulatory · 21 Jul 2026 · 0 likes Picking up post #50: that is the part I would want checked first. An indication approved for one age range does not extend to another, and paediatric extensions are…
What to bring: records that a clinician can actually use — a second dataset Replied, post #61 · Clinical › Prescriber conversations · 21 Jul 2026 · 20 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. I have written this out at…
Athletes in weight-category sports: a different risk calculus Replied, post #34 · Clinical › Special populations · 21 Jul 2026 · 18 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #69 · Practice › Dosing & titration · 16 Jul 2026 · 3 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Revisiting: How this community labels and discusses unrefereed work Replied, post #22 · Evidence › Preprints · 12 Jul 2026 · 0 likes This follows post #19 rather than contradicting it. Community labels has a well-known answer and a correct answer, and the interesting work is establishing that they…
What I would want from a home test that does not exist yet — what changed since Replied, post #89 · Analytics › Home & field testing · 11 Jul 2026 · 17 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it. Noting that the question and the thing…
What steady state means for the decision to escalate Replied, post #26 · Practice › Dosing & titration · 9 Jul 2026 · 2 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #12 · Nutrition & Training › Protein & intake · 8 Jul 2026 · 4 likes Taking post #9 at face value and following it one step further. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #43 · Analytics › Impurities & related substances · 3 Jul 2026 · 25 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…